CLINICAL_TRIALS
trial_result
· 2012-04-12
Clinical Trial Update: A Study of Raltegravir in a Diverse Cohort of HIV-Infected Patients (0518-055) [Phase 3]
Summary
Phase 3 trial of raltegravir in a diverse cohort of HIV-infected patients has completed, with results posted on 2012-04-12.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Human Immunodeficiency Virus | Phase 3 | Status: COMPLETED | Results posted: 2012-04-12